GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains attention beyond type 2 diabetes care
And the anti-inflammatory, neuroprotective properties of GLP-1 receptor activation may provide cumulative benefits over time
While the medication is designed for consistent weekly dosing on the same day each week, occasional schedule variations do occur
Studies report that it can cause up to a 2.2% reduction in HbA1c from baseline in T2D subjects [50]
Favorite Quote: Whether you think you can, or think you cant, youre right. Compare yourself to who you were yesterday, not to who someone else is today.